End-of-day quote
Shenzhen S.E.
23:00:00 29/04/2024 BST
|
5-day change
|
1st Jan Change
|
41.73
CNY
|
+0.34%
|
|
+8.96%
|
-19.05%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
26,346
|
44,361
|
33,154
|
20,525
|
21,573
|
17,463
|
-
|
-
|
Enterprise Value (EV)
1 |
26,468
|
43,015
|
32,367
|
21,551
|
23,243
|
19,422
|
19,083
|
17,463
|
P/E ratio
|
115
x
|
72.1
x
|
86.8
x
|
141
x
|
62.1
x
|
35.2
x
|
28.7
x
|
-
|
Yield
|
0.29%
|
0.29%
|
0.31%
|
0.14%
|
0.33%
|
0.66%
|
0.64%
|
-
|
Capitalization / Revenue
|
17
x
|
23.7
x
|
14.8
x
|
8.64
x
|
8.78
x
|
5.7
x
|
4.47
x
|
3.97
x
|
EV / Revenue
|
17
x
|
23
x
|
14.4
x
|
9.07
x
|
9.46
x
|
6.34
x
|
4.88
x
|
3.97
x
|
EV / EBITDA
|
64.6
x
|
51.4
x
|
57.3
x
|
63.1
x
|
39.7
x
|
15.7
x
|
15.6
x
|
-
|
EV / FCF
|
-
|
-1,124
x
|
-
|
-
|
-146
x
|
15.2
x
|
11.8
x
|
8.82
x
|
FCF Yield
|
-
|
-0.09%
|
-
|
-
|
-0.69%
|
6.58%
|
8.47%
|
11.3%
|
Price to Book
|
10.7
x
|
10.7
x
|
7.27
x
|
-
|
4.11
x
|
3.1
x
|
2.91
x
|
-
|
Nbr of stocks (in thousands)
|
401,000
|
413,163
|
415,305
|
416,583
|
418,486
|
418,486
|
-
|
-
|
Reference price
2 |
65.70
|
107.4
|
79.83
|
49.27
|
51.55
|
41.73
|
41.73
|
41.73
|
Announcement Date
|
27/02/20
|
25/03/21
|
06/04/22
|
23/04/23
|
19/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,554
|
1,870
|
2,246
|
2,377
|
2,456
|
3,066
|
3,909
|
4,402
|
EBITDA
1 |
410
|
836.5
|
564.7
|
341.4
|
585.4
|
1,238
|
1,220
|
-
|
EBIT
1 |
266.6
|
680.7
|
395.6
|
94.8
|
270.1
|
545.3
|
643.4
|
-
|
Operating Margin
|
17.15%
|
36.39%
|
17.61%
|
3.99%
|
11%
|
17.79%
|
16.46%
|
-
|
Earnings before Tax (EBT)
1 |
266.5
|
666.7
|
389.9
|
87.57
|
322.1
|
517.8
|
620.7
|
-
|
Net income
1 |
230.8
|
606.4
|
383.1
|
145.4
|
348
|
496.8
|
608.3
|
-
|
Net margin
|
14.85%
|
32.42%
|
17.06%
|
6.12%
|
14.17%
|
16.21%
|
15.56%
|
-
|
EPS
2 |
0.5700
|
1.490
|
0.9200
|
0.3500
|
0.8300
|
1.185
|
1.455
|
-
|
Free Cash Flow
1 |
-
|
-38.26
|
-
|
-
|
-159.6
|
1,278
|
1,617
|
1,980
|
FCF margin
|
-
|
-2.05%
|
-
|
-
|
-6.5%
|
41.69%
|
41.37%
|
44.98%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
103.27%
|
132.55%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
257.23%
|
265.83%
|
-
|
Dividend per Share
2 |
0.1900
|
0.3100
|
0.2500
|
0.0700
|
0.1700
|
0.2750
|
0.2667
|
-
|
Announcement Date
|
27/02/20
|
25/03/21
|
06/04/22
|
23/04/23
|
19/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
---|
Net sales
1 |
521.4
|
584.7
|
668.6
|
409.4
|
713.9
|
782.3
|
729.7
|
412.6
|
735.8
|
770.4
|
783.6
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
12.12
|
97.04
|
-21.65
|
18.6
|
0.8041
|
81.58
|
165.7
|
-
|
108.4
|
85.83
|
122.2
|
Operating Margin
|
2.32%
|
16.6%
|
-3.24%
|
4.54%
|
0.11%
|
10.43%
|
22.71%
|
-
|
14.73%
|
11.14%
|
15.6%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.1000
|
0.2000
|
0.0300
|
0.0200
|
0.1000
|
0.2300
|
0.3700
|
0.1000
|
0.2300
|
0.1900
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
06/04/22
|
26/04/22
|
24/08/22
|
28/10/22
|
23/04/23
|
25/08/23
|
24/10/23
|
19/04/24
|
19/04/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
122
|
-
|
-
|
1,026
|
1,670
|
1,958
|
1,619
|
-
|
Net Cash position
1 |
-
|
1,346
|
787
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.2984
x
|
-
|
-
|
3.005
x
|
2.853
x
|
1.582
x
|
1.327
x
|
-
|
Free Cash Flow
1 |
-
|
-38.3
|
-
|
-
|
-160
|
1,278
|
1,617
|
1,980
|
ROE (net income / shareholders' equity)
|
9.84%
|
21.3%
|
8.8%
|
-
|
6.89%
|
8.7%
|
10.1%
|
-
|
ROA (Net income/ Total Assets)
|
6.08%
|
13%
|
-
|
-
|
-
|
5.2%
|
7%
|
-
|
Assets
1 |
3,796
|
4,682
|
-
|
-
|
-
|
9,555
|
8,690
|
-
|
Book Value Per Share
2 |
6.140
|
10.00
|
11.00
|
-
|
12.50
|
13.50
|
14.30
|
-
|
Cash Flow per Share
2 |
1.380
|
1.560
|
1.260
|
-
|
2.180
|
2.190
|
0.2100
|
-
|
Capex
1 |
620
|
684
|
758
|
-
|
1,074
|
609
|
265
|
352
|
Capex / Sales
|
39.9%
|
36.59%
|
33.76%
|
-
|
43.72%
|
19.87%
|
6.79%
|
8%
|
Announcement Date
|
27/02/20
|
25/03/21
|
06/04/22
|
23/04/23
|
19/04/24
|
-
|
-
|
-
|
Last Close Price
41.73
CNY Average target price
50.98
CNY Spread / Average Target +22.15% Consensus |
1st Jan change
|
Capi.
|
---|
| -19.05% | 2.41B | | +12.55% | 9.06B | | -12.75% | 4.96B | | +42.38% | 4.47B | | +5.23% | 3.9B | | +21.01% | 2.41B | | -28.72% | 2.23B | | +11.13% | 2.02B | | +3.94% | 1.65B | | -0.50% | 1.64B |
Specialty & Advanced Pharmaceuticals
|